10-27743300-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_173576.3(MKX):c.116C>A(p.Ala39Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000569 in 1,405,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173576.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MKX | NM_173576.3 | c.116C>A | p.Ala39Asp | missense_variant | 2/7 | ENST00000419761.6 | NP_775847.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MKX | ENST00000419761.6 | c.116C>A | p.Ala39Asp | missense_variant | 2/7 | 2 | NM_173576.3 | ENSP00000400896 | P1 | |
MKX | ENST00000375790.9 | c.116C>A | p.Ala39Asp | missense_variant | 2/7 | 1 | ENSP00000364946 | P1 | ||
MKX | ENST00000460919.2 | c.116C>A | p.Ala39Asp | missense_variant | 1/5 | 3 | ENSP00000452751 | |||
MKX | ENST00000561227.1 | c.116C>A | p.Ala39Asp | missense_variant | 2/2 | 5 | ENSP00000453746 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000259 AC: 5AN: 193096Hom.: 0 AF XY: 0.0000281 AC XY: 3AN XY: 106818
GnomAD4 exome AF: 0.00000569 AC: 8AN: 1405652Hom.: 0 Cov.: 33 AF XY: 0.00000717 AC XY: 5AN XY: 697674
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 31, 2022 | The c.116C>A (p.A39D) alteration is located in exon 2 (coding exon 1) of the MKX gene. This alteration results from a C to A substitution at nucleotide position 116, causing the alanine (A) at amino acid position 39 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at